Review article · 22 Jan 2024
Conference abstractPublished 2019
Implementing modern cell engineering and process development approaches for affordable and sustainable biosimilar manufacturing
Ipca Laboratories Ltd., India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
I will give a General Overview of Biosimilars/ Biologics and opportunities for the Biopharma players followed by implementation of modern tools described below for affordable biosimilar and Biologisc development: 1. Implementation of Gene editing tools CRISPR and TALENS for cell line engineering and production improvement 2. Modern approaches for high producer cell line and robust upstream process development 3. Use of cutting edge technologies to improve biosimilar development and manufacturing 4. Factors influences protein expression and critical quality attributes including glycosylation of monoclonal antibodies 5. mAb glycosylation and its overall Impact on biosimilarity and product performance 6. Case studies on titer and quality improvement at clone and process level for affordable biosimilar development
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cell Biology: Research & Therapy.
Opinion · 29 Dec 2023
Cellular Homeostasis and Disease: Current Insights and Therapeutic Implications
Perspective · 29 Dec 2023
Cellular Reproduction and Reprogramming: Implications for Therapeutic Advancements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCell Biology: Research & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Sanjeev Gupta”

